Huirong Xu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Extracorporeal Membrane Oxygenation

Intensive Care Unit

Ejection Fraction

Top Venues

Animal models and experimental medicine

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Huirong Xu, Meiyue Dong, Ruikun Du, Chengcheng Zhang, Zinuo Chen, Guangyu Tian, Qinghua Cui, Kejian Li
Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology. Animal models and experimental medicine 7 (3) (2024)
Huirong Xu, Meiyue Dong, Ruikun Du, Chengcheng Zhang, Zinuo Chen, Guangyu Tian, Qinghua Cui, Kejian Li
Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology. Animal models and experimental medicine 7 (3) (2024)
Huirong Xu, Meiyue Dong, Ruikun Du, Chengcheng Zhang, Zinuo Chen, Guangyu Tian, Qinghua Cui, Kejian Li
Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology. Animal models and experimental medicine (2024)
Huirong Xu, Meiyue Dong, Ruikun Du, Chengcheng Zhang, Zinuo Chen, Guangyu Tian, Qinghua Cui, Kejian Li
Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology. Animal models and experimental medicine 7 (3) (2024)
Huirong Xu, Guangyu Tian, Chunli Wu, Xiaowen Sun, Kejian Li
Meta-analysis of the efficacy and safety of Xihuang Pills/capsules in adjuvant treatment of uterine cervical neoplasms. Medicine 102 (34) (2023)
Wentong Fang, Qian Li, Min Wang, Mingjie Zheng, Huirong Xu
DEC2 Serves as Potential Tumor Suppressor in Breast Carcinoma. Disease markers 2020 (2020)